A Study of AK0529 in Adults Patients Hospitalized With RSV Infection

Clinical trial NCT06942299 · COMPLETED

Trial details

NCT number: NCT06942299
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2023-07-20
Primary completion: 2024-06-28
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.